32 results
SC TO-T/A
TAK
Takeda Pharmaceutical Co
11 May 18
Third party tender offer statement (amended)
4:43pm
is confirmed by an independent expert) in a loss or liability for TiGenix and its subsidiaries (the “Group”), taken as a whole, having a negative impact of more
6-K
TAK
Takeda Pharmaceutical Co
11 Jul 22
Current report (foreign)
6:05am
The Takeda Pharmaceutical Pension Association is administered by designated or selected expert staff mainly from the areas of HR and finance, who … , the Association incorporates expert knowledge and consulting from external specialists in its pension fund management policy. In addition
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
14 Dec 23
Current report (foreign)
6:01am
or selected expert staff mainly from the areas of HR and finance, who are knowledgeable about corporate pension and pension fund management. Taking … into consideration the importance of securing long-term pension payment for employees, the Association incorporates expert knowledge and consulting from
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
12 Jul 23
Current report (foreign)
6:07am
as the Managing Organization - Principle 2.6 The Takeda Pharmaceutical Pension Association is administered by designated or selected expert staff mainly … of securing long-term pension payment for employees, the Association incorporates expert knowledge and consulting from external specialists in its
6-K
EX-1
TAK
Takeda Pharmaceutical Co
27 May 20
Current report (foreign)
6:03am
. Director who is an ASC Member Koji Hatsukawa is a Certified Public Accountant and has expert knowledge in finance and accounting. 4. Director who … as a professional expert throughout the course of audit, maintain professional skepticism, and perform the following: l We identify and assess the risks
6-K
EX-99.1
6m5rennm j7fq5rgx5
6 Jul 23
Current report (foreign)
6:18am
6-K
wakvn23h8sq
14 Jun 19
Current report (foreign)
6:17am
6-K
EX-99.1
z9msid6zd8ors98
31 May 22
Current report (foreign)
6:07am
6-K
EX-99.1
23vw9kc4ojl829
28 May 21
Current report (foreign)
6:01am
6-K
ju7cat93ojye
16 Jul 19
Current report (foreign)
8:50am
6-K
mmzc 87z9tl0d9uqht0l
19 Jul 21
Current report (foreign)
6:02am
6-K
w7nf pg5b
31 Jan 19
Current report (foreign)
6:07am
6-K
EX-99.1
r4we89xa wri6u
23 Jun 23
Current report (foreign)
6:13am
6-K
EX-99.1
3vmh2ztkzeug4 dd
30 May 23
Current report (foreign)
6:11am
6-K
i09z3o6jhskl
1 Nov 21
Current report (foreign)
6:04am
6-K
4fmm xuhipezoqy
29 Jul 20
Current report (foreign)
6:07am
20FR12B
EX-10.10
ljkzvehug1fu
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
DRS/A
EX-10.10
9xfbupn
16 Nov 18
Draft registration statement (amended)
12:00am
20FR12B/A
EX-10.10
zz73hhr2af my2zicjvi
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
6-K
EX-99.1
0xype6 1ci7s
29 Jun 21
Current report (foreign)
7:38am